# IPERIONX Ltd: financial statements, quarterly

IPX · Nasdaq · CIK 1898601 · [Materials](/sectors/materials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ipx.md) · [Financials](/companies/ipx/financials.md) · [Filings](/companies/ipx/filings.md) · [Insiders](/companies/ipx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ipx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2020-07-19) | period not labelled (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001140361-24-008601.md) | [1.7](/filings/0001140361-24-044628.md) | [5.7](/filings/0001898601-25-000013.md) | [11.9](/filings/0001898601-25-000013.md) | [33.2](/filings/0001898601-25-000013.md) | [54.8](/filings/0001898601-25-000013.md) |
| Current assets | $m | not reported | [1.7](/filings/0001140361-22-030925.md) | [5.8](/filings/0001140361-24-008601.md) | [12.8](/filings/0001140361-24-044628.md) | [41.5](/filings/0001898601-25-000013.md) | [58.9](/filings/0001898601-25-000013.md) |
| Total assets | $m | not reported | [2.8](/filings/0001140361-22-030925.md) | [9.9](/filings/0001140361-24-008601.md) | [22.8](/filings/0001140361-24-044628.md) | [55.4](/filings/0001898601-25-000013.md) | [105](/filings/0001898601-25-000013.md) |
| Current liabilities | $m | not reported | [0.6](/filings/0001140361-22-030925.md) | [2.1](/filings/0001140361-24-008601.md) | [1.6](/filings/0001140361-24-044628.md) | [3.1](/filings/0001898601-25-000013.md) | [8.4](/filings/0001898601-25-000013.md) |
| Total liabilities | $m | not reported | [1.0](/filings/0001140361-22-030925.md) | [2.5](/filings/0001140361-24-008601.md) | [2.2](/filings/0001140361-24-044628.md) | [4.1](/filings/0001898601-25-000013.md) | [12.6](/filings/0001898601-25-000013.md) |
| Shareholders' equity | $m | [0.0](/filings/0001140361-24-008601.md) | [1.8](/filings/0001140361-24-044628.md) | [7.4](/filings/0001140361-24-044628.md) | [20.6](/filings/0001898601-25-000013.md) | [51.3](/filings/0001898601-25-000013.md) | [92.4](/filings/0001898601-25-000013.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 339,384,066 at 2026-06-30, from the cover of the [20-F filed 2026-09-29](/filings/0001898601-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.